Accounting for less than two percent of the global pharmaceutical market, the Middle East has long been somewhat overlooked by many drug makers, most…

During a global virtual press briefing on 19 March 2020, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)…

Attila Fejer general manager of Eli Lilly in Romania gives his insights on the “deadly cocktail” of challenging policies that govern the…

From Turkey to Tajikistan, Bangladesh to Bahrain, and Russia to Rwanda, multinational pharma firms are increasingly situating wide-ranging management…

Eli Lilly’s president and general manager for the SAMETA (South Asia, Middle East, Turkey, and Africa) region, José Antonio Alas, discusses the…

Miha Kline has been with Eli Lilly for the past 15 years, becoming Country Manager Czech Republic and Slovakia four years ago. Kline shares his…

Multinational pharma company managers working abroad must adapt to new cultures and develop a deep understanding of local markets. Korea is no…

China’s pharma market is growing at an unprecedented pace and has become a key element of virtually all pharma multinationals’ international…

After climbing through the ranks from sales representative to leading business units at Eli Lilly Canada, François Gilbert took the reins of Eli…

Victor Cruz, VP-Manufacturing Puerto Rico and Brazil for Lilly del Caribe highlights the priorities in his new position and underlines the importance…

Puerto Rico’s close-knit pharmaceutical sector is aiming to attract new talent to the industry so as to further increase its global competitiveness.…

With more than 50 years of experience in pharmaceutical manufacturing, Puerto Rico is today a manufacturing base for 11 of the world’s 20 largest…